About Us

Nebulabio is a specialized biotechnology service provider with a global reputation for excellence in camelid-derived single-domain antibody (VHH, Nanobody) production. Our dedicated Llama VHH Antibody Production Service is built upon a deep understanding of camelid immunology, advanced recombinant protein expression, and rigorous purification science. Unlike standard antibody service providers, we focus exclusively on harnessing the unique power of the llama (Lama glama) immune system to generate highly stable, specific, and potent VHH binders. We serve pharmaceutical companies, diagnostic developers, and academic researchers who require not just discovery but also the reliable, scalable production of these unique reagents for functional assays, structural studies, diagnostic kit development, and pre-clinical evaluation. Our end-to-end service, managed by experts, ensures you receive high-quality, functional VHH antibodies tailored to your specific project requirements.

☞Principle of Llama VHH Antibody Production

Our service leverages a remarkable natural biological principle. Camelids, such as llamas, possess a unique adaptive immune system that generates a significant proportion of heavy-chain-only antibodies (HCAbs) alongside conventional antibodies. These HCAbs lack light chains and the first constant domain (CH1). Their antigen-binding capability is contained within a single variable domain, the VHH (also known as a Nanobody).

The process begins with the immunization of llamas. When exposed to an antigen, their immune system mounts a robust response, producing conventional antibodies and HCAbs specific to the target. The VHH domains derived from these HCAbs offer extraordinary advantages:

• Small Size & Stability: ~15 kDa, highly stable against temperature, pH, and proteolysis.

• Solubility & Expression: Highly soluble and express efficiently in microbial systems like E. coli and yeast.

• Unique Epitope Recognition: Their long, flexible CDR3 loops can access cryptic, concave epitopes (e.g., enzyme active sites, GPCR pockets) often inaccessible to conventional antibodies.

• Low Immunogenicity: While of camelid origin, VHHs display high homology to human VH sequences and can be easily humanized for therapeutic applications.

Our production service translates this biological principle into a reliable pipeline: we manage the immunization to elicit a strong VHH response, clone the resulting VHH repertoire, select specific binders, and then transition to recombinant expression systems for scalable, consistent production of your chosen VHH(s).

☞Llama VHH Antibody Production Process

Our production pipeline is a multi-stage, integrated process designed for quality and yield at every step.

 Phase 1: Llama Immunization & Immune Response Monitoring 

• Project Design & Antigen Preparation: We consult on antigen design (protein, peptide, cell, etc.) and formulation with appropriate adjuvants to maximize immune response diversity and titer.

• Ethical Immunization Program: Conducted at our certified animal facility under strict ethical guidelines. A multi-injection schedule over 6-8 weeks ensures a mature, high-affinity immune response.

• Serum Monitoring: Regular bleeds are taken to monitor antigen-specific antibody titers via ELISA, ensuring immunization proceeds optimally before the final lymphocyte harvest.

 Phase 2: VHH Gene Library Construction & Selection 

• Lymphocyte Isolation: Peripheral blood lymphocytes (PBLs) are collected from the immunized llama at the peak of the immune response.

• Phage Display Library Construction: RNA is extracted, and VHH genes are specifically amplified via RT-PCR using primers targeting the unique features of camelid HCAb mRNA. The genes are cloned into a phage display vector to create an immune VHH library.

• Biopanning for Specific Binders: The library is screened against your target antigen using our phage display platform. Through 3-4 rounds of selection, VHH clones with the desired affinity and specificity are isolated, sequenced, and identified.

 Phase 3: Recombinant VHH Expression & Small-Scale Production 

• Clone Selection & Vector Construction: The DNA sequence of the selected VHH clone(s) is codon-optimized for the chosen expression host (typically E. coli for cytoplasmic or periplasmic expression) and cloned into a high-expression vector (e.g., with a His-tag for purification).

• Expression Screening: Small-scale cultures are used to optimize expression conditions (temperature, inducer concentration, time).

• Small-Scale Purification: VHHs are expressed and purified via immobilized metal affinity chromatography (IMAC) using the His-tag, followed by size-exclusion chromatography (SEC) or dialysis for buffer exchange and polishing.

 Phase 4: Scale-Up Production & Quality Control 

• Fermentation Scale-Up: The optimal expression protocol is scaled to liter-scale fermentation in bioreactors for higher yield.

• Large-Scale Purification: IMAC and SEC are performed at scale to produce milligram to gram quantities of pure VHH.

• Comprehensive Quality Control (QC): Every batch undergoes stringent QC:

  Purity: >95% as assessed by SDS-PAGE and analytical SEC.

  Identity: Mass spectrometry (MS) confirms molecular weight.

  Activity & Affinity: ELISA or bio-layer interferometry (BLI) confirms binding activity and measures affinity (KD).

  Endotoxin & Sterility: Testing to meet required standards for in vitro or in vivo use.

• Formulation & Delivery: The purified VHH is concentrated, formulated into your specified buffer (e.g., PBS), sterile-filtered, aliquoted, and shipped on dry ice.

Figure1.Schematic illustration of production of the plant-derived anti-HER2 VHH-FcK antibody. 

☞Our Service Workflow

Our client-centric workflow ensures clear communication, transparency, and a collaborative partnership throughout the production journey.

 Step 1: Project Consultation & Quotation 

We discuss your antigen, required VHH specifications (affinity, yield, purity, tags, formulation), and intended use. A detailed project plan, timeline, and quote are provided.

 Step 2: Antigen Submission & Immunization Start 

You provide the purified antigen. Upon agreement, we initiate the ethical immunization protocol at our facility. You receive regular updates on immunization progress and serum titers.

 Step 3: Library Build & Binder Selection 

Following lymphocyte harvest, we construct the immune VHH library and perform biopanning. We deliver a report detailing the identified VHH sequences, their binding characteristics, and recommend the top clones for production.

 Step 4: Clone Selection & Production Agreement 

You select the preferred VHH clone(s) for scale-up. We finalize the production scale (mg to g) and specifications.

 Step 5: Process Development & Scale-Up Production 

Our expression team optimizes and executes the production run. We provide updates on fermentation yields and purification progress.

 Step 6: QC Release & Final Delivery 

The final product undergoes full QC. You receive a comprehensive Certificate of Analysis (CoA) detailing all analytical results, along with the purified VHH antibody in its final formulation.

 Our Service Process Flowchart: 

☞Applications of Llama VHH Antibodies

VHH antibodies produced through our service are transformative tools across numerous fields:

■ Therapeutic Development:

• Targeting Difficult Epitopes: Ideal for inhibiting protein-protein interactions, targeting ion channel pores, or modulating GPCRs.

• Multispecific Formats: Easy to engineer into bi- or tri-specific molecules due to their simple structure.

• Blood-Brain Barrier Crossing: Their small size facilitates engineering for CNS targets.

■ Diagnostic & Imaging Reagents:

• In Vitro Diagnostics (IVD): Superior stability extends shelf-life of lateral flow assays and ELISA kits.

• In Vivo Molecular Imaging: Rapid tissue penetration and blood clearance enable high-contrast PET, SPECT, or optical imaging for cancer and inflammation.

■ Research Tools:

• Superior Immunoassays: Provide high specificity and low background in Western blotting, immunohistochemistry (IHC), and flow cytometry.

• Intracellular Antibodies (Intrabodies): Can be expressed inside cells to inhibit, mislocalize, or tag proteins for live-cell imaging.

• Structural Biology: Their stability and small size facilitate crystallization for epitope mapping and protein complex structural studies.

■ Affinity Purification: Serve as highly specific and robust capture ligands for resin-based purification of complex proteins.

Partner with Nebulabio for a reliable, expert-led journey from antigen to purified, functional Llama VHH antibody. Our integrated service provides the unique advantages of Nanobodies with the assurance of professional production standards.